AQR Arbitrage’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

AQR Arbitrage’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-667,532	Closed	-$25.1M	–	1424
2021 Q1	$25.1M	Buy	+667,532	New	+$16.6M	0.9%	19

AQR Arbitrage's FPRX Position: Q2 2021 in Review

AQR Arbitrage sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 667,532 shares — an estimated $25.1M sold.

AQR Arbitrage first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $25.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

AQR Arbitrage reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
AQR Arbitrage sold 667,532 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $25.1M.
AQR Arbitrage first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
AQR Arbitrage's Five Prime Therapeutics, Inc. position peaked at $25.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on AQR Arbitrage's 13F filing for Q2 2021, filed 16 Aug 2021.